Recalls and suspensions

Subscribe to TGA safety information
6 April 2021
Product defect correction - lid magnet may dislodge and cause early battery depletion
23 March 2021
Recall of various medicines containing Artemisia annua and Artemisia absinthium - updated recalled medicines
23 December 2020
Recall due to presence of chloroform
23 December 2020
Recall - potential for split tablets to lead to ineffective dose

More safety information »

Safety information

Subscribe to TGA safety information
6 May 2021
The Therapeutic Goods Administration (TGA) has been closely monitoring suspected side effects (also known as adverse events) from the use …
30 April 2021
Update - suspension lifted after review
29 April 2021
Medicines Safety Update article
28 April 2021
Information about the TGA's safety monitoring of COVID-19 vaccines

More safety information »

News

Subscribe to TGA latest news and updates
7 May 2021
The TGA is seeking feedback on options to improve the Therapeutic Goods Advertising Code (No.2) 2018. Closing date: 18 June 2021
6 May 2021
Australian Public Assessment Report for Omalizumab
6 May 2021
Proposed amendments to the Poisons Standard. Closing date: 4 June 2021
6 May 2021
Australian Public Assessment Report for Olaparib

More news »